Lali's Law

Bill: 114-hr-4586
Sponsor: Rep. Dold, Robert J. [R-IL-10]
Introduced: 2016-02-23 in the House
Policy area: Health
Subjects: Drug therapy
Drug trafficking and controlled substances
Drug, alcohol, tobacco use
Emergency medical services and trauma care
First responders and emergency personnel
Health programs administration and funding
Health promotion and preventive care
Prescription drugs

Summary:
action_date: 2016-02-23
text: 

Lali's Law

 
This bill amends the Public Health Service Act to permit the Centers for Disease Control and Prevention to make grants to states that allow standing orders (documents that allow a person to acquire, dispense, or administer a prescription medication without a person-specific prescription) for opioid overdose reversal medication (e.g., naloxone). (Opioids are drugs with effects similar to opium, such as heroin and certain pain medications.)
 
Grants may be used for:
 
 
 developing standing orders for opioid overdose reversal medication for pharmacies;
 
encouraging pharmacies to dispense medication pursuant to such a standing order;
 
implementing guidelines and best practices for prescribing opioids, prescribing opioid overdose reversal medication with opioids, and discussing opioid overdose reversal medication with patients;
 
developing training for prescribers to use in educating the public on administration of opioid overdose reversal medication; and
 
educating the public on the availability and public health benefits of opioid overdose reversal medication.
 
 States must report on pharmacies that dispense opioid overdose reversal medication under a standing order and the number of pharmacists trained in educating the public on administration of opioid overdose reversal medication.
action_date: 2016-05-10
text: 

Lali's Law

 
(Sec. 2) This bill amends the Public Health Service Act to permit the Department of Health and Human Services to make grants to states that allow standing orders (documents that allow a person to acquire, dispense, or administer a prescription medication without a person-specific prescription) for opioid overdose reversal medication (e.g., naloxone). (Opioids are drugs with effects similar to opium, such as heroin and certain pain medications.)
 
Grants may be used for:
 
 
 developing standing orders for opioid overdose reversal medication for pharmacies;
 
encouraging pharmacies to dispense medication pursuant to such a standing order;
 
implementing best practices for prescribing opioids, prescribing opioid overdose reversal medication with opioids, and discussing opioid overdose reversal medication with patients;
 
developing training for prescribers to use in educating the public on administration of opioid overdose reversal medication; and
 
educating the public on the availability and public health benefits of opioid overdose reversal medication.
 
 
States must report on pharmacies that dispense opioid overdose reversal medication under a standing order and the number of pharmacists trained in educating the public on administration of opioid overdose reversal medication. 
 
(Sec. 3) As an offset, this bill reduces the authorization of appropriations for Centers for Disease Control and Prevention facilities.

action_date: 2016-05-12
text: 
(This measure has not been amended since it was reported to the House on May 10, 2016. The summary of that version is repeated here.)
 

Lali's Law

 
(Sec. 2) This bill amends the Public Health Service Act to permit the Department of Health and Human Services to make grants to states that allow standing orders (documents that allow a person to acquire, dispense, or administer a prescription medication without a person-specific prescription) for opioid overdose reversal medication (e.g., naloxone). (Opioids are drugs with effects similar to opium, such as heroin and certain pain medications.)
 
Grants may be used for:
 
 
 developing standing orders for opioid overdose reversal medication for pharmacies;
 
encouraging pharmacies to dispense medication pursuant to such a standing order;
 
implementing best practices for prescribing opioids, prescribing opioid overdose reversal medication with opioids, and discussing opioid overdose reversal medication with patients;
 
developing training for prescribers to use in educating the public on administration of opioid overdose reversal medication; and
 
educating the public on the availability and public health benefits of opioid overdose reversal medication.
 
 
States must report on pharmacies that dispense opioid overdose reversal medication under a standing order and the number of pharmacists trained in educating the public on administration of opioid overdose reversal medication. 
 
(Sec. 3) As an offset, this bill reduces the authorization of appropriations for Centers for Disease Control and Prevention facilities.


Legislative actions:
action_date: 2016-05-16
text: Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
action_date: 2016-05-12
text: Motion to reconsider laid on the table Agreed to without objection.
action_date: 2016-05-12
text: On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 415 - 4 (Roll no. 189). (text: CR 5/11/16 CR H2271)
action_date: 2016-05-12
text: Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 415 - 4 (Roll no. 189).(text: CR 5/11/16 CR H2271)
action_date: 2016-05-12
text: Considered as unfinished business. (consideration: CR H2317-2318)
action_date: 2016-05-11
text: At the conclusion of debate, the Yeas and Nays were demanded and ordered. Pursuant to the provisions of clause 8, rule XX, the Chair announced that further proceedings on the motion would be postponed.
action_date: 2016-05-11
text: DEBATE - The House proceeded with forty minutes of debate on H.R. 4586.
action_date: 2016-05-11
text: Considered under suspension of the rules. (consideration: CR H2270-2273)
action_date: 2016-05-11
text: Mr. Guthrie moved to suspend the rules and pass the bill, as amended.
action_date: 2016-05-10
text: Placed on the Union Calendar, Calendar No. 429.
action_date: 2016-05-10
text: Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 114-555.
action_date: 2016-05-10
text: Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 114-555.
action_date: 2016-04-28
text: Ordered to be Reported (Amended) by Voice Vote.
action_date: 2016-04-28
text: Committee Consideration and Mark-up Session Held.
action_date: 2016-04-27
text: Committee Consideration and Mark-up Session Held.
action_date: 2016-04-26
text: Committee Consideration and Mark-up Session Held.
action_date: 2016-04-25
text: Committee Consideration and Mark-up Session Held.
action_date: 2016-04-20
text: Forwarded by Subcommittee to Full Committee (Amended) by Voice Vote .
action_date: 2016-04-20
text: Subcommittee Consideration and Mark-up Session Held.
action_date: 2016-02-26
text: Referred to the Subcommittee on Health.
action_date: 2016-02-24
text: Sponsor introductory remarks on measure. (CR H862)
action_date: 2016-02-23
text: Referred to the House Committee on Energy and Commerce.
action_date: 2016-02-23
text: Introduced in House
action_date: 2016-02-23
text: Introduced in House